期刊文献+

Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS 被引量:12

Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS
在线阅读 下载PDF
导出
摘要 AIM:To gain new insights into tumor metabolism and to identify possible biomarkers with potential diagnostic values to predict tumor metastasis.METHODS:Human gastric cancer SGC-7901 cells were implanted into 24 severe combined immune deficiency (SCID) mice,which were randomly divided into metastasis group (n=8),non-metastasis group (n=8),and normal group (n=8).Urinary metabolomic information was obtained by gas chromatography/mass spectrometry (GC/MS).RESULTS:There were significant metabolic differences among the three groups (t test,P < 0.05).Ten selected metabolites were different between normal and cancer groups (non-metastasis and metastasis groups),and seven metabolites were also different between non-metastasis and metastasis groups.Two diagnostic models for gastric cancer and metastasis were constructed respectively by the principal component analysis (PCA).These PCA models were confirmed by corresponding receiver operating characteristic analysis (area under the curve=1.00).CONCLUSION:The urinary metabolomic profile is different,and the selected metabolites might be instructive to clinical diagnosis or screening metastasis for gastric cancer. AIM:To gain new insights into tumor metabolism and to identify possible biomarkers with potential diagnostic values to predict tumor metastasis.METHODS:Human gastric cancer SGC-7901 cells were implanted into 24 severe combined immune deficiency (SCID) mice,which were randomly divided into metastasis group (n=8),non-metastasis group (n=8),and normal group (n=8).Urinary metabolomic information was obtained by gas chromatography/mass spectrometry (GC/MS).RESULTS:There were significant metabolic differences among the three groups (t test,P 0.05).Ten selected metabolites were different between normal and cancer groups (non-metastasis and metastasis groups),and seven metabolites were also different between non-metastasis and metastasis groups.Two diagnostic models for gastric cancer and metastasis were constructed respectively by the principal component analysis (PCA).These PCA models were confirmed by corresponding receiver operating characteristic analysis (area under the curve=1.00).CONCLUSION:The urinary metabolomic profile is different,and the selected metabolites might be instructive to clinical diagnosis or screening metastasis for gastric cancer.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第6期727-734,共8页 世界胃肠病学杂志(英文版)
基金 Supported by The Key Program of Science and Technology Commission of Shanghai Municipality,Project No.09JC1411600 Natural Science Foundation of Shanghai,No.08ZR1411300
关键词 Metabolomic profile Gastric cancer Metastasis BIOMARKER Gas chromatography/mass spectrometry 代谢物 SGC 预测值 胃癌 MS 气相色谱/质谱 PCA模型 尿
作者简介 Correspondence to: Jin-Lian Chen,MD, Professor, Department of Gastroenterology, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, China. wqq_021002@ 163.com Telephone: +86-21-64369181 Fax: +86-21-64369181
  • 相关文献

参考文献3

二级参考文献23

  • 1[1]Moayyedi P,Ford A.Recent developments in gastroenterology.BMJ 2002; 325:1399-1402
  • 2[2]Sun J,Misumi J,Shimaoka A,Aoki K,Esaki F.Stomach cancer-related mortality.Eur J Cancer Prev 2001; 10:61-67
  • 3[3]Lambert R,Guilloux A,Oshima A,Pompe-Kirn V,Bray F,Parkin M,Ajiki W,Tsukuma H.Incidence and mortality from stomach cancer in Japan,Slovenia and the USA.Int J Cancer 2002; 97:811-818
  • 4[4]Kampschoer GH,Fujii A,Masuda Y.Gastric cancer detected by mass survey.Comparison between mass survey and outpatient detection.Scand J Gastroenterol 1989; 24:813-817
  • 5[5]Shiratori Y,Nakagawa S,Kikuchi A,Ishii M,Ueno M,Miyashita T,Sakurai T,Negami J,Suzuki T,Sato I.Significance of a gastric mass screening survey.Am J Gastroenterol 1985; 80:831-834
  • 6[6]Takemoto C,Isechi T,Matsumoto J,Kusano K,Mishige K,Nuruki F.Current status and problems of screening for gastric cancer using endoscopy.Nihon Shokaki Shudankenshin Gakkaishi 2004; 42:322-330 (in Japanese)
  • 7[7]Waye JD,Aabakken L,Armengol-Miro JR,Llorens P,Williams CB,Zhang QL.Screening for GI cancer and payment mechanisms.Gastrointest Endosc 2002; 55:453-454
  • 8[8]Whiting JL,Sigurdsson A,Rowlands DC,Hallissey MT,Field ing JW.The long term results of endoscopic surveillance of premalignant gastric lesions.Gut 2002; 50:378-381
  • 9[9]McColl KE.Screening for early gastric cancer.Gut 2005; 54:740-742
  • 10Keishiro Aoyagi,Kikuo Kouhuji,Shojiro Yano,Motoshi Miyagi,Takuya Imaizumi,Jinryo Takeda,Kazuo Shirouzu.VEGF significance in peritoneal recurrence from gastric cancer[J].Gastric Cancer.2005(3)

共引文献59

同被引文献87

  • 1Jin-Lian Chen,Jun-Duo Hu,Jing Fan,Jing Hong,Department of Gastroenterology,Shanghai Sixth People’s Hospital,Shanghai Jiao Tong University,Shanghai 200233,China Hui-Qing Tang,Jian-Zhong Gu,Shanghai Laboratory Animal Center,Chinese Academy of Sciences,Shanghai 201615,China.Metabolomics of gastric cancer metastasis detected by gas chromatography and mass spectrometry[J].World Journal of Gastroenterology,2010,16(46):5874-5880. 被引量:13
  • 2Shaukat A,Mongin SJ,Geisser MS.大便隐血检查可减少结直肠癌远期死亡率[J].中华结直肠疾病电子杂志,2013,2(4):206-206. 被引量:4
  • 3KatherineDCrew,AlfredINeugut.Epidemiology of gastric cancer[J].World Journal of Gastroenterology,2006,12(3):354-362. 被引量:191
  • 4Atsushi Tashiro,Masatoshi Sano,Koichi Kinameri,Kazutaka Fujita,Yutaka Takeuchi.Comparing mass screening techniques for gastric cancer in Japan[J].World Journal of Gastroenterology,2006,12(30):4873-4874. 被引量:24
  • 5欧阳珏,武明花,黄琛,李丹,周鸣,李小玲,李桂源.代谢组学及其在恶性肿瘤研究中的应用[J].中南大学学报(医学版),2007,32(2):221-225. 被引量:6
  • 6Yitao Jia,Min Liu,Wangang Huang,Zhenbao Wang,Yutong He,Jianhua Wu,Shuguang Ren,Yingchao Ju,Ruichao Geng,Zhongxin Li.Recombinant Human Endostatin Endostar Inhibits Tumor Growth and Metastasis in a Mouse Xenograft Model of Colon Cancer[J]. Pathology & Oncology Research . 2012 (2)
  • 7Natasha S. Stephens,Jesse Siffledeen,Xiaorong Su,Travis B. Murdoch,Richard N. Fedorak,Carolyn M. Slupsky.Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy[J].Journal of Crohn’s and Colitis.2012
  • 8Suya Hori,Shin Nishiumi,Kazuyuki Kobayashi,Masakazu Shinohara,Yukihisa Hatakeyama,Yoshikazu Kotani,Naoya Hatano,Yoshimasa Maniwa,Wataru Nishio,Takeshi Bamba,Eiichiro Fukusaki,Takeshi Azuma,Tadaomi Takenawa,Yoshihiro Nishimura,Masaru Yoshida.A metabolomic approach to lung cancer[J].Lung Cancer.2011(2)
  • 9Douglas E. Guggenheim,Manish A. Shah.Gastric cancer epidemiology and risk factors[J].J Surg Oncol.2012(3)
  • 10AtsukiIkeda,ShinNishiumi,MasakazuShinohara,TomooYoshie,NaoyaHatano,TatsuyaOkuno,TakeshiBamba,EiichiroFukusaki,TadaomiTakenawa,TakeshiAzuma,MasaruYoshida.Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer[J].Biomed Chromatogr.2012(5)

引证文献12

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部